Study of Association Between Maternal Uric Acid , Maternal and Fetal Outcome in Pregnant Women With Hypertension

Association of Maternal Uric Acid With Maternal Condition and Fetal Outcome in Pregnant Women With Hypertension

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01523327

Enrollment

Registered

2012-02-01

Start date

2011-10-31

Completion date

2012-10-31

Last updated

2012-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uric Acid and Hypertension in Pregnancy

Keywords

Uric acid

Brief summary

Association of maternal uric acid with maternal condition and fetal outcome in pregnant women with hypertension.

Detailed description

Association of maternal uric acid with maternal condition(renal function,liver function,...ect.) and fetal outcome(birth weight,APGER score) in pregnant women with hypertension.

Interventions

OTHERmeasuring protein creatinin ratio,serum uric acid

A non-deproteinized Jaffe reaction is employed to measure creatinine and urinary protein measured by an automated colorimetric assay using pyrogallol red and sodium molybdate. Measuring of serum uric acid by(2,4,6-tribromo-3-hydroxybenzoic acid)TBHBA by uricase method.

Study design

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* Age:18-40 years old * Gestational age:28-42 weeks gestation singleton pregnancy of living fetus * Non smoker

Exclusion criteria

* women who refuse the study * Any medical or obstetric disorders especially D.M.,renal disease,hepatic, cardiac disorders or gout arthritis, other than hypertension if present. * Previously elevated uric acid level. * Hemolytic or sickle cell anemia,urinary tract infection. * Use of diuretics or anti-inflammatory drugs.

Countries

Egypt

Contacts

Primary ContactNermin marzouk touma, M.B.,B.Ch

nermindave@gmail.com01222740182

Backup Contactnermin Marzouk touma, M.B.,B.Ch

nermindave@gmail.com0862636607

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026